Canther

Canther is a research laboratory focused on “CANcer Heterogeneity, Plasticity and Resistance to THERapies”, established in 2020. It operates as a collaboration between the University of Lille, CNRS, Inserm, Lille University Hospital (CHU Lille), Lille Pasteur Institute (IPL), Cancer Centre Oscar Lambret (COL), and Lille Research Institute against Cancer (IRCL). The lab comprises five teams, each specializing in unique mechanisms related to cancer research. Dr. Isabelle Van Seuningen's team focuses on resistance to chemotherapies, Dr. David Tulasne's team studies resistance to targeted therapies, Pr Bruno Quesnel's team specializes in tumor dormancy in leukemias, Pr Corinne Abbadie's team explores senescence and fibrosis mechanisms associated with cancer, and Pr Xuefen Le Bourhis's team delves into mechanisms of resistance associated with the metastatic process. Canther operates within the Health Care industry and despite the lack of disclosed information regarding its headquarters, recent investments, and investors, its collaborative structure and focus on cancer resistance mechanisms make it a promising venture in the field of cancer research and therapy.